تلاش
Balance de una década de política de drogas: Avances y Retos
Introducción Según el último Informe Mundial sobre las Drogas publicado por la Oficina de las Naciones Unidas contra la Droga y el Delito (UNODC, por sus siglas en inglés) correspondiente al año 2022, alrededor de 284 millones de personas de entre 15 y 64 años consumieron drogas.
WHO stakeholder survey on improving access to morphine for medical use
WHO launched a survey on assessing barriers, enablers, and pirority actions for improving access to morphine for medical use.
All Civil Society Organisation can contribute by filling out the survey before 31 August 2022.
The survey is...
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Background
In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly...
The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
Background
Beginning in the 1990s, non-medical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the...
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Paper presented at the commemoration of the 2022 International Day Against Drug Abuse & Illicit Trafficking, State House Conference Centre, Abuja, Nigeria.
The UNODC/PTRS demand reduction mentor at the UNODC Programme Office in Indonesia provided technical assistance to the National Narcotics Board (BNN) in conducting a national hybrid training for Government Officials on the UNODC Treatnet Family programme
On July 19th, 2022, the Director of Strengthening Government Institution, Deputy of Rehabilitation, BNN officially launched a national hybrid training on the UNODC Treatnet Family programme with 34 representatives from all BNN provinces and...
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Thirteenth Session)
ISSUP Nigeria would like to invite you to attend their next Bi-Monthly Webinar in the Knowledge Update Series. The Webinar topic will be Beyond Dependence: Alcohol-induced Disorders.
Learning Outcomes:
• Sensitization to the wide range...
Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [11C]Raclopride
Objectives: Positron emission tomography (PET) with [11C]raclopride has been applied to measure changes in the concentration of endogenous dopamine induced by pharmacological challenge or neuropsychological stimulation by evaluating the...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
کھانے کی خرابی اور اے او ڈی کا استعمال: ڈاکٹروں کو کیا جاننے کی ضرورت ہے
ایسوسی ایٹ پروفیسر سارہ میگوائر (ڈائریکٹر، انسائڈ آؤٹ انسٹی ٹیوٹ) کی طرف سے پیش کردہ اس ویبینار میں شرکت سے شرکاء سیکھیں گے:
- کھانے کی خرابی کی سب سے عام علامات کو کیسے پہچانیں؛
- کھانے کی خرابی کی مداخلت اور کارکن انہیں کیسے فراہم...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in the...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
World Drug Report 2022
The 2022 World Drug Report provides a global overview of the supply and demand of opiates, cocaine, cannabis, amphetamine-type stimulants and new psychoactive substances (NPS), as well as their impact on health.
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
نائجیریا کی یونیورسٹیوں میں نشے سے متعلق مطالعاتی پروگراموں کی توثیق: چیلنجز، مواقع، اور وکالت کی ضرورت
تعارف:
نائجیریا میں منشیات کے علاج کی خدمات تک رسائی کم ہے جس کی وجہ منشیات کے علاج کے عملے میں شدید کمی ہے۔ نائجیریا کی یونیورسٹیوں میں منشیات کی لت کے تربیتی پروگرام متعارف کروا کر افرادی قوت کی کمی کو دور کرنے کے منصوبے جاری ہیں۔ یہ...
AddictologyIssue 1/2022
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors
Abstract
Cocaine addiction is a significant medical and public concern. Despite decades of research effort, development of pharmacotherapy for cocaine use disorder remains largely unsuccessful. This may be partially due to insufficient...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.